NCT01400594

Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail

A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety & Efficacy of HTU-520 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 182 (actual)
• Sponsor: Hisamitsu Pharmaceutical Co., Inc. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of HTU-520 in subjects with clinically diagnosed onychomycosis of the great toenail.

Detailed description

A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety \& Efficacy of HTU-520 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail

Conditions

• Onychomycosis

Interventions

Type	Name	Description
DRUG	HTU-520 Patch	Terbinafine hydrochloride patch
OTHER	Placebo Patch	Treatment with Placebo Patch

Timeline

• Start date: 2011-07-01
• Primary completion: 2013-01-01
• Completion: 2013-01-01
• First posted: 2011-07-22
• Last updated: 2015-06-04

Locations

37 sites across 1 country: United States